New Brunswick, NJ, USA –Natreon, Inc., a leading supplier of scientifically proven Ayurvedic ingredients for the dietary supplement, personal care and food and beverage markets , has received an equity investment from DSM Venturing B.V., the corporate venture capital arm of the global Life Sciences and Materials Sciences company, Royal DSM.
Natreon’s CEO & Chairman, Dr. Sanni Raju, commented that “We are pleased to welcome DSM as a strategic investor as we expand Natreon’s clinically proven, high quality Ayurvedic product lines. DSM is a global leader in the dietary supplement market and their expertise and domain knowledge will help accelerate our growth. ”
Greg McParland, Senior Investment Manager of DSM Venturing says: “Natreon’s focus on rigorous science and clinically demonstrated natural herbal supplements separates them from their peers. Their products are focused on highly relevant health and wellness categories that consumers are demanding. We are looking forward to supporting the Natreon team as they expand their business.”
About Natreon Inc.
Natreon, Inc., located in New Jersey with a state of the art R&D facility in Kolkata, India, is focused on developing and marketing clinically backed Ayurvedic products. Natreon’s current product portfolio includes Capros® for heart health, Sensoril® for stress and cognition, PrimaVie® for mitochondrial energy and collagen gene up regulation, Crominex® for blood glucose support and heart health, AyuFlex® for joint health and Ayuric™ for hyperuricemia. Several other products are in the R&D pipeline.
Capros®, Sensoril®, PrimaVie®, Crominex®, AyuFlex® and Ayuric™ are trademarks of Natreon, Inc.
About DSM – Bright Science – Brighter Living™
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences, DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM and its associated companies deliver annual net sales of about €10 billion with approximately 25,000 employees. The company is listed on Euronext Amsterdam. More information can be found at www.dsm.com.
